Tagged Articles

Bayer 339 articles

Women want Essure cases in state court


Nearly five dozen women suing Bayer over claims that its permanent birth control device Essure perforated their uteruses and is linked to other injuries asked a California federal judge to send their case back to state court, arguing that only state law applies, according to Law360. The case was originally filed in Contra Costa County Superior Court in February, but was removed to federal court a month later. The complaint alleges Bayer violated California negligence, strict products liability, warranty and fraud statues. Bayer argued the case belonged in federal court because it implicates the Federal Food, Drug and Cosmetic Act ... Read More

Eliquis lot recalled due to packaging error

blood cells

A packaging error has prompted Bristol-Myers Squibb to recall one lot of the blood thinner Eliquis (apixaban) 5 milligram (mg) tablets. It was discovered that one of the bottles in the lot contained the 2.5mg tablets instead of the labeled 5mg tablets. The recall only affects Eliquis 5mb tablets in 60-count bottles imprinted with the Lot# HN0063 and the expiration date of September 2019. The two tablet strengths have distinct differences in appearance, which may indicate to the user that he is taking the wrong pill. But if a patient fails to notice this difference, he may be at risk ... Read More

Wrong blood thinner dose poses a-fib patient risk


About one-sixth of people in the U.S. with the heart condition atrial fibrillation taking a newer blood thinner to prevent strokes may not be taking the proper dose, putting them at risk for a stroke or uncontrolled bleeding, according to a study published in the Journal of the American College of Cardiology. The study, conducted by researchers with the Mayo Clinic in Rochester, Minnesota, involved nearly 15,000 patients treated with Eliquis, Pradaxa or Xarelto for atrial fibrillation from October 2010 to September 2015. They found that 16 percent of patients were taking doses inconsistent with Food and Drug Administration (FDA)-approved ... Read More

Family says Xarelto caused fatal brain bleed


What killed Sharyn Orr? The 67-year-old grandmother had a laundry list of medical problems, any of which could have taken her life, said attorneys defending drug makers Johnson & Johnson’s Janssen Pharmaceuticals and Bayer. They argue that her high blood pressure caused her fatal brain bleed. But attorneys representing Sharyn’s husband Joseph say it was the blood thinner Xarelto that caused the massive brain hemorrhage that took her life. And Janssen and Bayer, makers of the drug, failed to warn users of the risk of uncontrolled bleeds with use of Xarelto that could result in death. Both sides gave their opening ... Read More

Lawsuit: Xarelto makers put profits over patients


A lawsuit filed against Johnson & Johnson’s Janssen Pharmaceuticals and Bayer alleges the drugmakers put profits over patients, which led to the “completely avoidable” death of Sharyn M. Orr. The grandmother died in May 2015 at the age of 67 after suffering a brain hemorrhage allegedly caused by the drug companies’ blood thinner, Xarelto, reported FiercePharma. Orr’s lawsuit, filed on behalf of her husband Joseph, is the second bellwether to go to trial among about 19,000, most of which are pending in a multidistrict litigation (MDL) in the U.S. District Court in the Eastern District of Louisiana. Those suing Janssen and ... Read More

Pradaxa blood thinner death trial set for June


As the first bellwether cases in a large multidistrict litigation (MDL) alleging bleeding risks with Janssen Pharmaceuticals and Bayer’s blood thinner Xarelto head toward trial, a lawsuit against another blood thinner is making its way to court as well. The Liu family is suing Boehringer Ingelheim Pharmaceuticals for the wrongful death of their family member, Zhensheng, who died in November 2012 after a fall caused uncontrollable bleeding his brain, according to Law360. At the time of his death, Zhensheng was taking Pradaxa, which in 2010 became the first medication approved in a new class of blood thinners. Boehringer Ingelheim faced thousands ... Read More

Latest Xarelto trial jury selection underway


Jury selection in the second bellwether trial involving bleeding risks with Johnson & Johnson’s Janssen Pharmaceuticals and Bayer’s blood thinner Xarelto begins this week. The case is part of a massive multidistrict litigation (MDL) pending in U.S. District Court for the Eastern District of Louisiana accusing the drug companies of not adequately warning doctors or their patients of Xarelto bleeding risks. Citing the Jere Beasley Report, Mass Tort Nexus explains that Xarelto was approved by the Food and Drug Administration (FDA) in 2011 and is used to prevent strokes in patients with atrial fibrillation, to prevent or treat deep vein thrombosis and ... Read More

Second Xarelto bellwether underway this week


Jury selection has begun in the second bellwether trial involving alleged bleeding injuries with the blood thinner Xarelto. Johnson & Johnson’s Janssen Pharmaceuticals and Bayer face nearly 19,000 Xarelto lawsuits, with the majority of cases pending in a massive multidistrict litigation (MDL) currently underway in the U.S. District Court in the Eastern District of Louisiana. Xarelto was approved in 2011 and is used to prevent strokes in patients with atrial fibrillation, to treat or prevent deep vein thrombosis and pulmonary embolism, and to prevent blood clots in patients who have recently undergone hip or knee replacement surgery. Those suing Xarelto makers Janssen ... Read More

Xarelto makers cannot skirt injury claims


People suing Johnson & Johnson’s unit Janssen Pharmaceutical and Bayer over claims that their blood thinner Xarelto caused uncontrolled bleeding told a Louisiana federal court that the drug companies should not be able to skirt claims that rely on allegations that those suing the company previously dropped, according to Law360. Janssen and Bayer are seeking to dismiss with prejudice “abandoned allegations,” but the alleged victims of Xarelto side effects argue that the drug companies cannot move for summary judgment on such grounds. “Defendants contend that several ‘facts’ have been ‘abandoned’ and they are therefore entitled to have these facts dismissed. ... Read More

Xarelto lawsuits mount before second trial


The number of Xarelto lawsuits alleging bleeding injuries are nearing 19,000 with the majority of cases pending in a massive multidistrict litigation (MDL) currently underway in the U.S. District Court, Eastern District of Louisiana. Other litigation has been established in state courts in Pennsylvania, Delaware, California and Missouri. Canada has its own class action filed against the company as well. Johnson & Johnson’s Janssen Pharmaceuticals, and Bayer, makers of the blockbuster blood thinner, will face plaintiffs again at the second Xarelto bellwether trial in the MDL in New Orleans. Those suing over Xarelto side effects claim that Janssen and Bayer ... Read More